3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
4
Thoracic
2
Other solid neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Small Cell Lung Carcinoma
1
Mesothelioma, Malignant
1
Head and Neck Neoplasms
1
Interventions
pembrolizumab
4
belinostat
2
SS1(dsFv)PE38
2
Cisplatin
2
venetoclax
1
rovalpituzumab tesirine
1
durvalumab
1
cemiplimab
1
budigalimab
1
avelumab
1
atezolizumab
1
Topotecan
1
Tissue Banks
1
Thiotepa
1
Tamoxifen
1
Tablets
1
Sorafenib
1
Sirolimus
1
Radiotherapy
1
Quality of Life
1
Pemetrexed
1
Patient Reported Outcome Measures
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Fluorouracil
1
Filgrastim
1
Drug Therapy
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Tissue Banks
×
Other solid neoplasm
×
Clear all
NCT07550049
2026-04-24
COMETH
University of Kansas Medical Center
Not yet recruiting
110 enrolled